Ameriprise
CLOV icon

Ameriprise’s Clover Health Investments CLOV Stock Holding History

Ameriprise’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-132,585
Closed -$406K – 4099
2025
Q3 		$406K Buy
132,585
+1,993
+2% +$5.69K ﹤0.01% 3696
2025
Q2 		$364K Sell
130,592
-101,600
-44% -$334K ﹤0.01% 3637
2025
Q1 		$834K Sell
232,192
-11,578
-5% -$46.5K ﹤0.01% 3281
2024
Q4 		$768K Sell
243,770
-10,830
-4% -$38.7K ﹤0.01% 3357
2024
Q3 		$718K Buy
+254,600
New +$583K ﹤0.01% 3356

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise's CLOV Position: Q4 2025 in Review

Ameriprise sold out of Clover Health Investments (CLOV) in Q4 2025, closing a stake of 132,585 shares — an estimated $406K sold.

Ameriprise first reported a position in CLOV in Q3 2024 and held it in 5 quarters. The position peaked at $834K in Q1 2025. 193 funds tracked by Wall St. Rank hold CLOV as of Q4 2025.

  • Ameriprise reported no remaining Clover Health Investments position as of Q4 2025 after selling out during the quarter.
  • Ameriprise sold 132,585 Clover Health Investments shares in Q4 2025, an estimated $406K.
  • Ameriprise first reported a position in Clover Health Investments in Q3 2024 and held it in 5 quarters.
  • Ameriprise's Clover Health Investments position peaked at $834K in Q1 2025.
  • 193 funds tracked by Wall St. Rank held Clover Health Investments as of Q4 2025.

Based on Ameriprise's 13F filing for Q4 2025, filed 17 Feb 2026.